Peptide Mimetic Drugs for Modulating Thrombosis and Hemostasis.

Drug Dev Res

Joint Department of Biomedical Engineering, North Carolina State University and University of North Carolina at Chapel-Hill, Raleigh, North Carolina, 27606.

Published: September 2017

Preclinical Research Hemostasis is the complex physiological process that stems bleeding at an injury site while simultaneously maintaining unobstructed circulation in other areas of the body. This system is kept in balance with finely tuned regulation by pro- and antithrombotic agents. When this balance is thrown out of equilibrium, uncontrolled bleeding, or thrombotic complications can occur. Because of the high number of hemostatic disorders, researchers are continually searching for improved technologies for controlling coagulation. Recently, peptide mimetic strategies have been employed to target and regulate various stages of the coagulation cascade. In this review, we present an overview of the coagulation cascade and provide a summary of various peptide-mimetic approaches for its modulation. Drug Dev Res 78 : 236-244, 2017. © 2017 Wiley Periodicals, Inc.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ddr.21407DOI Listing

Publication Analysis

Top Keywords

peptide mimetic
8
coagulation cascade
8
mimetic drugs
4
drugs modulating
4
modulating thrombosis
4
thrombosis hemostasis
4
hemostasis preclinical
4
preclinical hemostasis
4
hemostasis complex
4
complex physiological
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!